XML 35 R24.htm IDEA: XBRL DOCUMENT v3.23.1
Note 7 - Share-based Compensation (Tables)
3 Months Ended
Mar. 31, 2023
Notes Tables  
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
  

Three Months Ended March 31,

 
  

2023

  

2022

 

Expected term (in years)

  6.25   6.25 

Expected volatility

  52%  67%

Risk-free rate

  3.55%  3.96%

Dividend rate

      
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
  

Number of Shares

  

Weighted-Average Exercise Price Per Option

  

Weighted- Average Remaining Contractual Life (in years)

 

Shares underlying outstanding awards at December 31, 2022

  601,220  $3.54   4.85 

Granted

  9,333   8.97     

Exercised

  -        

Cancelled/Forfeited

  (2,863)  11.41     

Shares underlying outstanding awards at March 31, 2023

  607,690  $3.60   5.18 

Exercisable options at March 31, 2023

  503,445  $2.40   4.47 
Nonvested Restricted Stock Shares Activity [Table Text Block]
  

Three Months Ended March 31, 2023

 
  

Number of RSUs

  

Weighted Average Grant Date Fair Value

 

Outstanding at December 31, 2022

  145,637  $10.68 

Granted

  62,500   8.94 

Vested

  (26,284)  11.16 

Cancelled/Forfeited

  (2,908)  8.94 

Outstanding at March 31, 2023

  178,945  $10.04 
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
   Three Months Ended March 31,
  

2023

  

2022

 

Direct product costs

 $17,665  $1,321 

Research and development

  65,731   8,432 

Sales and marketing

  45,459   14,211 

General and administrative

  139,785   8,892 
  $268,640  $32,856